Invention Grant
- Patent Title: High concentration antibody formulations
-
Application No.: US15144256Application Date: 2016-05-02
-
Publication No.: US10064946B2Publication Date: 2018-09-04
- Inventor: Timothy D. Osslund
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/00 ; C07K16/18 ; C07K16/22 ; A61K47/14 ; A61K9/00 ; A61K47/12 ; A61K47/24
Abstract:
Discloses herein are high concentration antibody formulations comprising an anti-sclerostin immunoglobulin and an acetate salt and/or an acetate buffer and methods of use.
Public/Granted literature
- US20160235849A1 High Concentration Antibody Formulations Public/Granted day:2016-08-18
Information query
